Abstract
A panel of experts of the Italian Society of Pediatric Endocrinology and Diabetology comprehensively discussed and approved the Italian recommendations regarding self-monitoring of blood glucose, continuous glucose monitoring and other measures of glycemic control in children and adolescents with type 1 diabetes. After an extensive review of the literature, we took these issues into account: self-monitoring blood glucose, continuous glucose monitoring, glycemic variability, glycosuria, ketonuria, ketonemia, glycated hemoglobin, fructosamine and glycated albumin, logbook, data downloading, lancing devices, carbohydrate counting, and glycemic measurements at school. We concluded that clinical guidelines on self-management should be developed in every country with faithful adaptation to local languages and taking into account specific contexts and local peculiarities, without any substantial modifications to the international recommendations. We believe that the National Health Service should provide all necessary resources to ensure self-monitoring of blood glucose and possibly continuous glucose monitoring of all children and adolescents with type 1 diabetes, according to the standards of care provided by these recommendations and internationally.
Similar content being viewed by others
References
Gruppo di Studio sul Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica (2011) Consensus guidelines: raccomandazioni per l’automonitoraggio e l’autocontrollo in bambini e adolescenti con diabete tipo 1. Acta Biomed 82:3–48
Dias J, Martins S, Carvalho S, Marques O, Antunes A (2013) Mauriac syndrome still exists. Endocrinol Nutr Mar 26. doi:10.1016/j.endonu.2012.12.005. [Epub ahead of print]
Lawrence RD (1926) The effect of exercise on insulin action in diabetes. BMJ 1(3406):648–650
Joslin EP (1927) The outlook for the diabetic. Cal West Med 26:328–331
Lestradet H (1958) Bulletin de l’Information de l’Association pour l’Aide aux Jeunes Diabetiques
The Diabetes Control and Complications Trial Research Group (1994) Effect of intensive diabetes treatment on the development and progression of long term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr 125:177–188
Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Research Group (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Intervention and Complications (EDIC) study. JAMA 290:2159–2167
Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM, National Academy of Clinical Biochemistry (2011) Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 34:1419–1423
Garg SK, Hirsch IB (2011) Self-monitoring of blood glucose. Int J Clin Pract Suppl 170:1–9
Garg SK (2013) Standardization of self-monitoring of blood glucose and continuous glucose monitoring reporting. Diabetes Technol Therap 15:193
Reichel A, Rietzsch H, Ludwig B, Röthig K, Moritz A, Bornstein SR (2013) Self-adjustment of insulin dose using graphically depicted self-monitoring of blood glucose measurements in patients with type 1 diabetes mellitus. J Diabetes Sci Technol 7:156–162
Ziegler R, Heidtmann B, Hilgard D, Hofer S, Rosenbauer J, Holl R, DPV-Wiss-Initiative (2011) Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 12:11–17
Buckingham B, Block J, Burdick J, Kalajian A, Kollman C, Choy M, Wilson DM, Chase P, Diabetes Research in Children Network (2005) Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Therap 7:440–447
Hirsch IB, Bode BW, Childs BP, Close KL, Fisher WA, Gavin JR, Ginsberg BH, Raine CH, Verderese CA (2008) Self-Monitoring of Blood Glucose (SMBG) in insulin and non insulin using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization and research. Diabetes Technol Therap 10:419–439
Ito T, Kamoi K, Minagawa S, Kimura K, Kobayashi A (2010) Patient perceptions of different lancing sites for self-monitoring of blood glucose: a comparison of fingertip site with palm site using the OneTouch Ultra blood glucose monitoring system. J Diabetes Sci Technol 4:906–910
Jungheim K, Koschinsky T (2002) Glucose monitoring at the arm: risky delays of hypoglycemia and hyperglycemia detection. Diabetes Care 25:956–960
Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2009) Assessment and monitoring of glycaemic control in children and adolescents with diabetes. Pediatr Diabetes 10(Suppl 12):71–81
Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults. NICE clinical guidelines CG15. http://www.nice.org.uk/cg15. Accessed 11 Apr 2013
Vanelli M, Cerutti F, Chiarelli F, Lorini R, Meschi F, MCDC-Italy Group (2005) Nationwide cross-sectional survey of 3560 children and adolescents with diabetes in Italy. J Endocrinol Invest 28:692–699
Hood KK, Peterson CM, Rohan JM, Drotar D (2009) Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics 124:e2–e10
Heinemann L, Freckmann G, Koschinsky T (2013) Considerations for an institution for evaluation of diabetes technology devices to improve their quality in the European Union. J Diabetes Sci Technol 7:542–547
Thorpe GH (2013) Assessing the quality of publications evaluating the accuracy of blood glucose monitoring systems. Diabetes Technol Ther 15:253–259
Baumstark A, Pleus S, Schmid C, Link M, Haug C, Freckmann G (2012) Lot-to lot variability of test strips and accuracy assessment of systems for self-monitoring of blood glucose according to ISO 15197. J Diabetes Sci Technol 6:1076–1086
Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL (1987) Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 10:622–628
Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C (2012) System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. J Diabetes Sci Technol 6:1060–1075
Faustino EVS, Hirshberg EL, Bogue CW (2012) Hypoglycemia in critically ill children. J Diabetes Sci Technol 6:48–57
Raccah D, Sulmont V, Reznik Y, Guerci B, Renard E, Hanaire H, Jeandidier N, Nicolino M (2009) Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the Real Trend study. Diabetes Care 32:2245–2250
Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G, Jasinskiene E, De Block C, Carrette O, Castañeda J, Cohen O, for The Interpret Study Group (2013) Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Therap 15:273–280
Gandrud LM, Xing D, Kollman C, Block JM, Kunselman B, Wilson DM, Buckingham BA (2007) The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age. Diabetes Technol Therap 9:307–316
Schiaffini R, Ciampalini P, Fierabracci A, Spera S, Borrelli P, Bottazzo GF, Crino A (2002) The continuous glucose monitoring system (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. Diabetes Metab Res Rev 18:324–329
Golicki DT, Golicka D, Groele L, Pankowska E (2008) Continuous glucose monitoring system in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 51:233–240
Chetty VT, Almulla A, Odueyungbo A, Thabane L (2008) The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in type 1 diabetic patients: a systematic review. Diabetes Res Clin Pract 81:79–87
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV (2009) Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 32:1947–1953
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O’Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D (2009) The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 32:1378–1383
Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J (2011) Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 34:795–800
Kordonouri O, Pankowska E, Rami B, Kapellen T, Coutant R, Hartmann R, Lange K, Knip M, Danne T (2010) Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 53:2487–2495
Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV (2012) Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes 13:6–11
Scaramuzza AE, Iafusco D, Rabbone I, Bonfanti R, Lombardo F, Schiaffini R, Buono P, Toni S, Cherubini V, Zuccotti GV (2011) Use of integrated real-time continuous glucose monitoring/insulin pump system in children and adolescents with type 1 diabetes: a 3-year follow-up study. Diabetes Technol Therap 13:99–103
Frontino G, Bonfanti R, Scaramuzza A, Rabbone I, Meschi F, Rigamonti A, Battaglino R, Favalli V, Bonura C, Sicignano S, Gioia E, Zuccotti GV, Cerutti F, Chiumello G (2012) Sensor-augmented pump therapy in very young children with type 1 diabetes: an efficacy and feasibility observational study. Diabetes Technol Therap 14:762–764
Battelino T, Conget I, Olsen B, Schutz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J (2012) The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 55:3155–3162
Gilliam LK, Hirsch IB (2009) Practical aspects of real-time continuous glucose monitoring. Diabetes Technol Therap 11(suppl 1):S75–S82
Wójcicki JM (1995) Mathematical descriptions of the glucose control in diabetes therapy. Analysis of the Schlichtkrull “M”-value. Horm Metab Res 27:1–5
Fritzsche G, Kohnert KD, Heinke P, Vogt L, Salzsieder E (2011) The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Therap 13:319–325
Baghurst PA (2011) Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Therap 13:296–302
McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Therap 7:253–263
Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC (2004) Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 53:955–962
Paty BW, Senior PA, Lakey JR, Shapiro AM, Ryan EA (2006) Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Therap 8:165–173
Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W (1998) Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 21:1870–1875
Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W (2006) Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29:2433–2438
Hayford JT, Weydert JA, Thompson RG (1983) Validity of urine glucose measurements for estimating plasma glucose concentration. Diabetes Care 6:40–44
Rotblatt MD, Koda-Kimble MA (1987) Review of drug interference with urine glucose tests. Diabetes Care 10:103–110
Samuelsson U, Ludvigsson J (2002) When should determination of ketonemia be recommended? Diabetes Technol Therap 4:645–650
Guerci B, Tubiana-Rufi N, Bauduceau B, Bresson R, Cuperlier A, Delcroix C, Durain D, Fermon C, Le Floch JP, Le Devehat C, Melki V, Monnier L, Mosnier-Pudar H, Taboulet P, Hanaire-Broutin H (2005) Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis. Diabetes Metab 31:401–406
Guerci B, Benichou M, Floriot M, Bohme P, Fougnot S, Franck P, Drouin P (2003) Accuracy of an electrochemical sensor for measuring capillary blood ketones by finger stick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 26:1137–1141
Auchterlonie A, Okosieme OE (2013) Preventing diabetic ketoacidosis: do patients adhere to sick-day rules? Clin Med 13:120
Goldstein DE, Little RR, Wiedmeyer HM, England JD, Rohlfing CL, Wilke AL (1994) Is glycohemoglobin testing useful in diabetes mellitus? Lessons from the diabetes control and complication trial. Clin Chem 40:1637–1640
Little RR, Sacks DB (2009) HbA1c: how do we measure it and what does it mean? Curr Opin Endocrinol Diabetes Obes 16:113–118
Little RR, Sacks DB (2009) A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol 3:446–451
Gruppo di LAvoro dei Delegati Working Group (A1c delegates WG): Andrea Mosca (coordinator), Dario Iafusco, Franco Meschi, Branca MT, Carta M, Genna ML, Giorda CB, Ghidelli R, Ghislandi G, Lapolla A, Buondonno Lombardi V, Lovagnini CA, Marra M, Medea G, Pizzini A, Rossi F, Scalpone R, Tofini G, Trovati M, Zaninotto M (2011) The implementation of international standardization of glycated hemoglobin A “red-letter-day” for HbA1c in Italy: 1/1/11—Italian recommendations of GLAD working group (A1c delegates WG). J Endocrinol Invest 35:353–356
Italian GLAD Working Group (A1c delegates WG) (2010) Recommendations for the implementation of international standardization of glycated haemoglobin in Italy. Clin Chem Lab Med 48:623–626
Kilpatrick E, Garry JW (2010) Improving accuracy, ensuring—the future for reporting. Diabetes Voice 55:40–42
Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, Calles-Escandon J, Russell GB, Freedman BI (2008) Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 73:1062–1068
Heinemann L (2008) Finger pricking and pain: a never ending story. J Diabetes Sci Technol 2:919–921
Heinemann L, Boecker D (2011) Lancing: quo vadis? J Diabetes Sci Technol 5:966–981
Nakayama T, Kudo H, Sakamoto S, Tanaka A, Mano Y (2008) Painless self-monitoring of blood glucose at finger sites. Exp Clin Endocrinol Diabetes 116:193–197
Hood KK, Peterson CM, Rohan JM, Drotar D (2009) Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics 124:e1171–e1179
Enander R, Gundevall C, Strömgren A, Chaplin J, Hanas R (2012) Carbohydrate counting with a bolus calculator improves post-prandial blood glucose levels in children and adolescents with type 1 diabetes using insulin pumps. Pediatr Diabetes. doi: 10.1111/j.1399-5448.2012.00883.x
Smart C, Aslander-van Vliet E, Waldron S (2011) Nutritional Management. Global IDF/ISPAD guideline for Diabetes in Childhood and Adolescence 66–69
Association American Diabetes, Clarke W, Deeb LC, Jameson P, Kaufman F, Klingensmith G, Schatz D, Silverstein JH, Siminerio LM (2013) Diabetes care in the school and day care setting. Diabetes Care 36(suppl 1):S75–S79
Gonder-Frederick LA, Zrebiec JF, Bauchowitz AU, Ritterband LM, Magee JC, Cox DJ, Clarke WL (2009) Cognitive function is disrupted by both hypo-and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diabetes Care 32:1001–1006
Bergenstal RM, Gavin JR, 3rd Global Consensus Conference on Glucose Monitoring Panel (2005) The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med 118(Suppl 9A):1S–6S
Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H, Endocrine Society (2011) Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96:2968–2999
Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamborlane W, Battelino T, Consensus Forum Participants (2012) Use of continuous glucose monitoring in children and adolescents. Pediatr Diabetes 13:215–228
Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM (2013) Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Therap 15:198–211
Conflict of interest
None of the authors has any conflict of interest to disclose regarding the preparation and writing of the recommendations included in the present paper. Other disclosures, however, are as follows. A.S. received a consulting fee for membership of a steering committee from Medtronic, a speaking fee from Abbott and a research grant from Menarini. V.C. received a consulting fee from Eli Lilly, Sanofi and Menarini. St.T. received a consulting fee as Principal Investigator from Roche and a consulting fee for board membership from Novo Nordisk, Eli Lilly and Lifescan. R.B. received a consulting fee from Medtronic, Roche, the Movi Group (Animas) and Sanofi. P.B. received a consulting fee from Roche and Sanofi. Francesca Cardella received a consulting fee from Roche and Sanofi. G.d.A. is a member of the Bayer Advisory Board. A.P.F. received consulting fee from Sanofi. F.L. received a consulting fee from Roche and Sanofi. I.R. received a consulting and speaking fee from Roche and Lifescan and a consulting fee from Eli Lilly. R.S. received a consulting fee from Roche and Sanofi. So.T. received consulting fee from Sanofi. S.Z. received a speaking fee from Roche and a consulting fee from Eli Lilly and Sanofi. D.I. received consulting fee from Sanofi. A.C.M.M. and G.F. do not have any conflict of interest.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Communicated by Massimo Porta.
Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology members are given in “Appendix”.
Appendix: Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology
Appendix: Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology
Claudia Arnaldi, Viterbo; Patrizia Banin, Ferrara; Fabrizio Barbetti, Rome; Luciano Beccaria, Lecco; Marzia Benelli, Lecce; Rosario Berardi, Siena; Martina Biagioni, Ancona; Giuliana Bianchi, Varese; Carla Bizzarri, Rome; Annalisa Blasetti, Chieti; Adriana Bobbio, Aosta; Stefano Boccato, Treviso; Riccardo Bonfanti, Milan, Franco Bontempi, Mantua; Mariella Bruzzese, Locri; Pietro Buono, Università Federico II, Naples; Francesco Cadario, Novara; Valeria Calcaterra, Pavia; Alessandra Cannatà, Polistena (RC); Marco Cappa, Rome; Roberta Cardani, Varese; Francesca Cardella, Palermo; Giuliana Marcella Cardinale, Casarano (LE); Ines Carloni, Ancona; Vincenzo Castaldo, Caserta; Vittoria Cauvin, Trento; Franco Cerutti, Turin; Anna Maria Cester, Ancona; Valentino Cherubini, Ancona; Margherita Chessa, Cagliari, Francesco Chiarelli, Chieti; Giovanni Chiari, Parma; Giuseppe Chiumello, Milan; Mario Cicchetti, Campobasso; Dante Cirillo, Magenta; Felice Citriniti, Catanzaro; Giuseppe Citro, Potenza; Maria Susanna Coccioli, Francavilla; Mario Cotellessa, Sanremo/Imperia; Antonino Crinò, Rome; Giuseppe d’Annunzio, Genoa; Fiorella De Berardinis, Fuscaldo; Gianpaolo De Filippo, Benevento; Giovanni De Giorgi, Perugia; Filippo De Luca, Messina; Rosaria De Marco, Cosenza; Maurizio Delvecchio, San Giovanni Rotondo; Elena Faleschini, Trieste; Giovanni Federico, Pisa; Anna Rita Fifi, Arezzo; Franco Fontana, Tortona (AL); Adriana Franzese, Università Federico II, Naples; Elda Frezza, Bari; Annapaola Frongia, Cagliari; Giulio Frontino, Milan; Alberto Gaiero, Savona; Alfonso Galderisi, Padua; Francesco Gallo, Brindisi; Luigi Gargantini, Treviglio (BG); Silvia Ghione, Varese; Chiara Giorgetti, Ancona; Antonella Gualtieri, Avezzano (AQ); Monica Guasti, Firenze; Lucia Guerraggio, Tradate (VA); Dario Iafusco, Seconda Università, Naples; Antonio Iannilli, Ancona; Dario Ingletto, Tricase (LE); Carmine Iossa, Caserta; Brunella Iovene, Parma; Lorenzo Iughetti, Modena; Peter Kaufmann, Bolzano; Alfonso La Loggia, Caltanissetta; Nicola Lazzaro, Crotone; Lorenzo Lenzi, Florence; Riccardo Lera, Alessandria; Rosanna Lia, Roccella Jonica (RC); Donatella Lo Presti, Catania; Fortunato Lombardo, Messina; Renata Lorini, Genoa; Sonia Lucchesi, Livorno; Sergio Luceri, Castrovillari (CS); Simona Filomena Madeo, Modena; Claudio Maffeis, Verona; Benedetta Mainetti, Forlì; Francesco Mammi, Locri; Maria Luisa Manca Bitti, Rome; Marco Marigliano, Verona; Alessandra Marinari, Foggia; Anna Maria Marinaro, Sassari; Gianfranco Meloni, Sassari; Alberto Marsciani, Rimini; Lisa Mastrangelo, Foggia; Costanzo Mastrangelo, Foggia; Franco Meschi, Milan; Domenico Minasi, Polistena (RC); Adelaide Minenna, San Giovanni Rotondo (BA); Nicola Minuto, Genoa; Carlamaria Monciotti, Padua; Gianfranco Morganti, Busto Arsizio (VA); Enza Mozzillo, Naples; Rosa Nugnes, Università Federico II, Naples; Emanuela Paradiso, Pinerolo (TO); Daniela Pardi, Massa Carrara; Bruno Pasquino, Bolzano; Ippolita Patrizia Patera, Rome; Cristina Pennati, Treviglio (BG); Rossella Pepe, Florence; Barbara Piccini, Florence; Angelo Perrotta, Campobasso; Elvira Piccinno, Bari; Leonardo Pinelli, Verona; Gavina Piredda, Olbia; Mauro Pocecco, Cesena; Giuseppe Ponzi, Casarano (LE); Elena Prandi, Brescia; Barbara Predieri, Modena; Francesco Prisco, Naples; Maria Quinci, Mazara del Vallo (TP); Ivana Rabbone, Turin; Maria Rossella Ricciardi, Cagliari; Andrea Rigamonti, Milan; Carlo Ripoli, Cagliari; Alberto Sabbion, Verona; Silvana Salardi, Bologna; Alessandro Salvatoni, Varese; Caterina Salvo, Palermo; Giuseppina Salzano, Messina; Anna Saporiti, Varese; Rita Sardi, Lucca; Andrea Scaramuzza, Milan; Riccardo Schiaffini, Rome; Eleonardo Schieven, Vicenza; Mirella Scipione, Bologna; Cristina Soci, Grosseto; Miriam Soro, Oristano; Luisa Spallino, Como; Filomena Stamati, Castrovillari (CS); Tosca Suprani, Cesena; Silvia Savastio, Novara; Rosa Anna Taccardi, Matera; Luis Tarchini, Ravenna; Letizia Tomaselli, Catania; Sonia Toni, Florence; Giorgio Tonini, Trieste; Cataldo Torelli, Bari; Gianluca Tornese, Trieste; Michela Trada, Sanremo/Imperia; Stefano Tumini, Chieti; Giuliana Valerio, Università Parthenope, Naples; Maurizio Vanelli, Parma; Roberto Vanini, Erba; Marina Vascotto, Siena; Amedeo Vergerio, Feltre; Matteo Viscardi, Milan; Silvana Zaffani, Verona; Maria Zampolli, Como; Manuela Zanatta, Udine; Giorgio Zanette, Pordenone; Angela Zanfardino, Seconda Università, Naples; Clara Zecchino, Bari; Maria Antonietta Zedda, Cagliari; Stefano Zucchini, Bologna; Gian Vincenzo Zuccotti, Milan.
Rights and permissions
About this article
Cite this article
Scaramuzza, A., Cherubini, V., Tumini, S. et al. Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. Acta Diabetol 51, 173–184 (2014). https://doi.org/10.1007/s00592-013-0521-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-013-0521-7